41 related articles for article (PubMed ID: 3101711)
1. Estrogenic activities of estradiol enantate and ethinylestradiol compared at a clinical level.
Moguilevsky JA; Wiemeyer JC; Sagasta CL; Leiderman S
Arzneimittelforschung; 1986 Nov; 36(11):1671-4. PubMed ID: 3101711
[TBL] [Abstract][Full Text] [Related]
2. Experimental findings on the estrogenic activity of estradiol enantate.
Wiemeyer JC; Guerreiro RB; Fernandez M; Sagasta CL
Arzneimittelforschung; 1986 Nov; 36(11):1667-70. PubMed ID: 3814224
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic studies of estradiol enantate in menopausic women.
Wiemeyer JC; Fernandez M; Moguilevsky JA; Sagasta CL
Arzneimittelforschung; 1986 Nov; 36(11):1674-7. PubMed ID: 3814225
[TBL] [Abstract][Full Text] [Related]
4. Effect of estrogens and progesterone on gonadotropin and prolactin release in a patient with androgen insensitivity.
Nicoletti I; Filipponi P; Fedeli L; Santori PA; Santeusanio F
Obstet Gynecol; 1981 Oct; 58(4):527-32. PubMed ID: 6792578
[TBL] [Abstract][Full Text] [Related]
5. No effect of ethinylestradiol treatment on melatonin secretion in healthy pubertal girls.
Commentz J; Willig R
Exp Clin Endocrinol Diabetes; 1995; 103(1):52-7. PubMed ID: 7621105
[TBL] [Abstract][Full Text] [Related]
6. Feedback effects of estradiol and progesterone upon gonadotropin and prolactin release.
March CM; Marrs RP; Goebelsmann U; Mishell DR
Obstet Gynecol; 1981 Jul; 58(1):10-6. PubMed ID: 6787487
[TBL] [Abstract][Full Text] [Related]
7. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
[TBL] [Abstract][Full Text] [Related]
8. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects.
Helgason S
Acta Obstet Gynecol Scand Suppl; 1982; 107():1-29. PubMed ID: 6282033
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of prolactin secretion by estrogen in hypogonadal women.
Yen SS; Ehara Y; Siler TM
J Clin Invest; 1974 Feb; 53(2):652-5. PubMed ID: 11344580
[TBL] [Abstract][Full Text] [Related]
10. The influence of chronic exposure to low frequency pulsating magnetic fields on concentrations of FSH, LH, prolactin, testosterone and estradiol in men with back pain.
Woldanska-Okonska M; Karasek M; Czernicki J
Neuro Endocrinol Lett; 2004 Jun; 25(3):201-6. PubMed ID: 15349086
[TBL] [Abstract][Full Text] [Related]
11. Double-blind crossover clinical pharmacology study comparing moxestrol (R 2858) and ethinyl estradiol in postmenopausal women.
Robyn C; Vekemans M; Rozencweig M; Chigot D; Raynaud JP
J Clin Pharmacol; 1978 Jan; 18(1):29-34. PubMed ID: 338643
[TBL] [Abstract][Full Text] [Related]
12. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women.
Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R
Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393
[TBL] [Abstract][Full Text] [Related]
13. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
Usuki S; Kondoh K; Kubo T
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
[TBL] [Abstract][Full Text] [Related]
14. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
15. Effect of several estrogens on serum gonadotropin levels in postmenopausal women.
Franchimont P; Legros JJ; Meurice J
Horm Metab Res; 1972 Jul; 4(4):288-92. PubMed ID: 5086200
[No Abstract] [Full Text] [Related]
16. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
Tresguerres JA; Esquifino AI
Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409
[TBL] [Abstract][Full Text] [Related]
17. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
Schneider WH; Schmid R; Spona J
Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
[TBL] [Abstract][Full Text] [Related]
18. Episodic secretion of LH and FSH after ovariectomy. Secretory patterns in response to estrogen and progesterone.
Wallach EE; DeCherney AH; Russ D; Duckett G; Garcia CR; Root AW
Obstet Gynecol; 1973 Feb; 41(2):227-33. PubMed ID: 4684207
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropins and prolactin during estrogen replacement therapy.
Helgason S; Carlström K; Damber MG; von Schoultz B
Acta Obstet Gynecol Scand; 1981; 60(5):515-6. PubMed ID: 6795895
[No Abstract] [Full Text] [Related]
20. The effect in post-menopausal women of natural human and artificial oestrogens on the concentration in serum of prolactin.
Andersen JR; Schroeder E; Lebech PE
Acta Endocrinol (Copenh); 1980 Dec; 95(4):433-7. PubMed ID: 6779473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
